Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Limitations of current therapies
2 evidence topics · 3 sources
Summary
In the 2022 U.S. survey, 38.3% of adults who tried to quit used counseling or medication, and recent successful cessation was reported by 8.8%. The cytisine-versus-varenicline evidence in the 2024 meta-analysis was rated low certainty. The Cochrane review identified imprecision in the evidence concerning serious adverse events.